NO910982D0 - Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller. - Google Patents

Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.

Info

Publication number
NO910982D0
NO910982D0 NO910982A NO910982A NO910982D0 NO 910982 D0 NO910982 D0 NO 910982D0 NO 910982 A NO910982 A NO 910982A NO 910982 A NO910982 A NO 910982A NO 910982 D0 NO910982 D0 NO 910982D0
Authority
NO
Norway
Prior art keywords
uratoxydase
microorganisms
expression vector
gene coding
active protein
Prior art date
Application number
NO910982A
Other languages
English (en)
Other versions
NO910982L (no
NO308139B1 (no
Inventor
Daniel Caput
Pascual Ferrara
Jean-Claude Guillemot
Mourad Kaghad
Richard Legoux
Gerard Loison
Elisabeth Larbre
Johannes Lupker
Pascal Leplatois
Marc Salome
Patrick Laurent
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8909550A external-priority patent/FR2649720A1/fr
Priority claimed from FR8917466A external-priority patent/FR2656530B1/fr
Priority claimed from PCT/FR1990/000532 external-priority patent/WO1991000909A1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO910982D0 publication Critical patent/NO910982D0/no
Publication of NO910982L publication Critical patent/NO910982L/no
Publication of NO308139B1 publication Critical patent/NO308139B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0044—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
    • C12N9/0046—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7) with oxygen as acceptor (1.7.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
NO910982A 1989-07-13 1991-03-12 FremgangsmÕte for fremstilling av rekombinant protein som har spesifikk uratoksydaseaktivitet, rekombinant gen som koder for proteinet, ekspresjonsvektor samt vertsceller som inneholder de rekombinante gen NO308139B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR8909550A FR2649720A1 (en) 1989-07-13 1989-07-13 Recombinant gene which encodes a protein such as urate oxidase
FR8917466A FR2656530B1 (fr) 1989-12-29 1989-12-29 Gene recombinant pour une expression dans les cellules eucaryotes d'une proteine telle que l'urate oxydase.
FR9001368A FR2657785A2 (fr) 1989-12-29 1990-02-06 Gene recombinant pour une expression dans les cellules animales d'une proteine telle que l'urate oxydage.
PCT/FR1990/000532 WO1991000909A1 (fr) 1989-07-13 1990-07-13 Proteine a activite urate oxydase, gene recombinant codant pour celle-ci, vecteur d'expression, micro-organismes et cellules transformees

Publications (3)

Publication Number Publication Date
NO910982D0 true NO910982D0 (no) 1991-03-12
NO910982L NO910982L (no) 1991-05-10
NO308139B1 NO308139B1 (no) 2000-07-31

Family

ID=27446701

Family Applications (1)

Application Number Title Priority Date Filing Date
NO910982A NO308139B1 (no) 1989-07-13 1991-03-12 FremgangsmÕte for fremstilling av rekombinant protein som har spesifikk uratoksydaseaktivitet, rekombinant gen som koder for proteinet, ekspresjonsvektor samt vertsceller som inneholder de rekombinante gen

Country Status (3)

Country Link
US (2) US5382518A (no)
KR (1) KR0159107B1 (no)
NO (1) NO308139B1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458574B1 (en) * 1996-09-12 2002-10-01 Transkaryotic Therapies, Inc. Treatment of a α-galactosidase a deficiency
SK1662000A3 (en) * 1997-09-05 2000-08-14 Pentapharm Ag Expression vector for improved production of polypeptides in yeast
US20060188971A1 (en) * 1998-08-06 2006-08-24 Duke University Urate oxidase
US6783965B1 (en) 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
CA2728907C (en) * 1998-08-06 2015-11-24 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
ES2352451T3 (es) 1998-08-06 2011-02-18 Duke University Urato oxidasa.
US7192729B2 (en) 1999-07-06 2007-03-20 General Atomics Methods for assaying homocysteine
US6376210B1 (en) 1999-07-06 2002-04-23 General Atomics Methods and compositions for assaying analytes
ES2367257T3 (es) 2002-04-25 2011-10-31 Shire Human Genetic Therapies, Inc. Tratamiento de deficit de alfa-galactosidasa a.
HU229626B1 (hu) 2005-04-11 2014-03-28 Savient Pharmaceuticals Urát oxidáz változat és alkalmazása
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
US8148123B2 (en) * 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
HU229068B1 (en) 2005-04-11 2013-07-29 Savient Pharmaceuticals Variant forms of urate oxidase and use thereof
JP2008545665A (ja) * 2005-05-23 2008-12-18 ユニベルシテ ドゥ ジュネーブ 高体温による処置のための注入可能な超常磁性ナノ粒子および高体温インプラントを形成するための使用
CN100406560C (zh) * 2006-03-15 2008-07-30 中国人民解放军军事医学科学院微生物流行病研究所 一种表达黄曲霉尿酸氧化酶的方法及其专用基因
KR101288027B1 (ko) * 2006-04-12 2013-07-22 새비언트 파마수티컬즈 인크. 양이온 계면활성제를 이용한 단백질 정제 방법
RU2535038C2 (ru) 2009-06-25 2014-12-10 Криэлта Фармасьютикалз ЭлЭлСи Способы и наборы для прогнозирования риска инфузионных реакций и опосредованной антителами потери ответа при терапии пэгилированной уриказой с помощью мониторинга содержания мочевой кислоты в сыворотке крови
KR102557569B1 (ko) * 2021-03-04 2023-07-20 전남대학교산학협력단 메타노사에타 콘실리에서 유래한 티로실-tRNA 합성효소 및 이를 이용한 단백질 생산방법
KR20240031241A (ko) * 2021-06-29 2024-03-07 주식회사 프로앱텍 Bcn 링커를 이용한 요산산화효소-알부민 컨쥬게이트의 생산 방법 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1529675A (fr) * 1967-03-29 1968-06-21 Applic Biochimiques Soc Et Urate oxydase à haute activité et sa préparation
US4431739A (en) * 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein

Also Published As

Publication number Publication date
US5541098A (en) 1996-07-30
KR0159107B1 (ko) 1998-11-16
KR920701443A (ko) 1992-08-11
NO910982L (no) 1991-05-10
NO308139B1 (no) 2000-07-31
US5382518A (en) 1995-01-17

Similar Documents

Publication Publication Date Title
NO910982L (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
DK0667912T3 (da) Defekte adenovirusvektorer og anvendelse heraf i genterapi
DK0939767T3 (da) Procin faktor VIII og hybrider deraf
DK217889D0 (da) Rekombinant-dna-udtrykkelsesvektorer og dna-forbindelser, der koder for desacetoxycephalosporin c synthetase
EP0571442A4 (en) CYTOKIN INDUCIBLE PROTEIN TSG-14, ITS ENCODING DNA AND THEIR USE.
EP0585257A4 (en) DNA AND AMINO ACID SEQUENCE SPECIFIC TO NATURAL K KILLER CELLS.
DK317288D0 (da) Hybridprotein af humant protein c og dets fremstilling samt dna, som koder det
DK224985D0 (da) Peptider, og midler indeholdende peptiderne
DK35483A (da) Expressionsvectorer for catechol-2,3-oxygenase, de vundne enzymer og deres anvendelse
ATE202570T1 (de) Gene, die für macif proteine kodieren, expressionsvektoren mit diesem genen, und transformantenzellen mit diesem proteinen
NO972063L (no) Isolert BMP-reseptorkinaseprotein, DNA-sekvens, rekombinant ekspresjonsvektor samt vertscelle
NO974811D0 (no) CNS-utvekstmodulatorer, preparater, celler og fremgangsmåter som omfatter og anvender slike
DK366589D0 (da) Humant protein c-mutant, dens fremstilling og dna, som koder derfor
DK0745122T3 (da) Galninreceptor, nukleinsyrer, transformerede celler og anvendelser heraf
DE3682358D1 (de) Expressionsvektoren zur verwendung in e. coli.
DK447083A (da) Dna, som koder for humant interferon-gamma, rekombinant-dna indeholdende denne dna, mikroorganisme indeholdende rekombinant-dna'en og fremgangsmaade til fremstilling af humant interferon-gamma-polypeptid
EP0970192A4 (en) NUCLEIC ACID ENCODING AN ALGU $ i PROTEIN (M. TUBERCULOSIS)
EP0659884A3 (en) Carrot 16kd protein, gene encoding this protein, and plazmid containing this gene.
NO981707L (no) Xylanase, oligonukleotidsekvens som koder for xylanase og anvendelse derav
NO974713L (no) Gener som koder for lymfocyttinterferon-regulatorisk faktor (LSIRF) polypeptider
TW342413B (en) Novel toxins isolated from Bracon Hebetor
NZ237463A (en) Protein phosphatase inhibitor-1 (ppi-1), dna encoding it, vectors and host cells
ATE320496T1 (de) Testisspezifische, menschliche proteinase, svph1- 8
DK43393D0 (da) Dna-sekvens, der koder for et enzym
DK0758384T3 (da) Leishmania-hovedprotein, nucleinsyre, som koder for dette protein, og anvendelser deraf

Legal Events

Date Code Title Description
SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: RASBURICASE; NAT. REG. NO/DATE: NO , EP/1/00/17 20010614; FIRST REG. NO/DATE: EP , EP/1/00/17 20010223

Spc suppl protection certif: 2001018

Filing date: 20011030

Extension date: 20150713

MK1K Patent expired
SPCX Expiry of an spc

Free format text: PRODUCT NAME: RASBURICASE; NAT. REG. NO/DATE: NO , EP/1/00/17 20010614; FIRST REG. NO/DATE: EP , EP/1/00/17 20010223;

Spc suppl protection certif: 2001018

Effective date: 20150713